Dr. Leung Wai Shing - Infectious Disease
Specialist in Infectious Disease
Highlights
- MCHK RegisteredVerified
- Specialist in Infectious DiseaseBachelor of Medicine and Bachelor of Surgery (MBBS) · Hong Kong College of Physicians · Medical degree 1999
- InsuranceBeing compiled｜See details
About
Dr. Leung Wai Shing is a registered Infectious Disease specialist in Hong Kong.
Education
Specialist in Infectious Disease
- Bachelor of Medicine and Bachelor of Surgery (MBBS)Bachelor of Medicine and Bachelor of Surgery (MBBS)1999
Hong Kong Academy of Medicine fellowships
- FHKCPFellow, Hong Kong College of Physicians
Source: Hong Kong Academy of Medicine Fellows Register, checked 12 Sep 2026
Insurance
Insurance plans being compiled
We're collecting insurance plan data per clinic. For confirmation, contact the clinic directly.
Are you Dr. Leung Wai Shing? Claim page and update insurance →
FAQ
Is Dr. Leung Wai Shing any good?
Dr. Leung Wai Shing is a registered Infectious Disease specialist in Hong Kong. Qualifications and registration come from the Hong Kong Medical Council. ok.med does not rate or rank doctors.
What does Dr. Leung Wai Shing do?
Dr. Leung Wai Shing practises in Infectious Disease.
Are you Dr. Leung Wai Shing? Claim this page to update and manage.
ClaimResearch and publications
23 papers · 12 most recent shown
Filter by paper topic
Topics come from medical classifications on these PubMed papers, not from the doctor's listed services.
- Stability and Predictors of Phenotypic Age Acceleration among Virally Suppressed Asians with HIV over Five Years.The journals of gerontology. Series A, Biological sciences and medical sciences · 2026
- Real-world clinical and laboratory changes after switching to two-drug regimen in HIV-suppressed individuals: 48 weeks and beyond.HIV medicine · 2026
- Boosting of serum neutralizing activity against the Omicron variant among recovered COVID-19 patients by BNT162b2 and CoronaVac vaccines.EBioMedicine · 2022
- Mitochondrial regulation of acute extrafollicular B-cell responses to COVID-19 severity.Clinical and translational medicine · 2022
- The differential impacts of early detection and accelerated antiretroviral therapy on the epidemiologic trend of sexually acquired HIV infection in Hong Kong.PloS one · 2022
- Phylogenomic analysis of COVID-19 summer and winter outbreaks in Hong Kong: An observational study.The Lancet regional health. Western Pacific · 2021
- Intra-host non-synonymous diversity at a neutralizing antibody epitope of SARS-CoV-2 spike protein N-terminal domain.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2021
- Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.The Lancet. Infectious diseases · 2020
- Consistent Detection of 2019 Novel Coronavirus in Saliva.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
- Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial.Lancet (London, England) · 2020
- Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans.Science (New York, N.Y.) · 2020
- Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses.Immunity · 2020
Publication data comes from PubMed / Europe PMC and is matched automatically by name and affiliation. Every entry links to the source.
For reference only. Not medical advice. Read full disclaimer